Cargando…

Polatuzumab vedotin for B-cell lymphoma

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738690/
https://www.ncbi.nlm.nih.gov/pubmed/33363310
http://dx.doi.org/10.18773/austprescr.2020.069
_version_ 1783623173601755136
collection PubMed
description
format Online
Article
Text
id pubmed-7738690
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-77386902020-12-23 Polatuzumab vedotin for B-cell lymphoma Aust Prescr New Drugs NPS MedicineWise 2020-10-22 2020-12 /pmc/articles/PMC7738690/ /pubmed/33363310 http://dx.doi.org/10.18773/austprescr.2020.069 Text en (c) NPS MedicineWise http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Polatuzumab vedotin for B-cell lymphoma
title Polatuzumab vedotin for B-cell lymphoma
title_full Polatuzumab vedotin for B-cell lymphoma
title_fullStr Polatuzumab vedotin for B-cell lymphoma
title_full_unstemmed Polatuzumab vedotin for B-cell lymphoma
title_short Polatuzumab vedotin for B-cell lymphoma
title_sort polatuzumab vedotin for b-cell lymphoma
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738690/
https://www.ncbi.nlm.nih.gov/pubmed/33363310
http://dx.doi.org/10.18773/austprescr.2020.069